International Patent: METHODS FOR IDENTIFYING ENDOTHELIAL CELL-MEDIATED CAD RISK AND SUSCEPTIBILITY TO LDL CHOLESTEROL

GENEVA, July 18 -- THE BRIGHAM AND WOMEN'S HOSPITAL, INC. filed a patent application (US2026/010804) for “METHODS FOR IDENTIFYING ENDOTHELIAL CELL-MEDIATED CAD RISK AND SUSCEPTIBILITY TO LDL CHOLESTEROL”. With publication no. WO/2026/152007, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12Q 1/6883

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....